A variety of scoring mechanisms exist to quantify IBD patients’ symptoms and quality of life. However, patients’ symptom experiences are highly variable; different patients experience different symptoms, and the same symptoms result in different levels of disability in different patients. To address these differences, the use of individualized outcome measures has been advocated. In individual outcome measures, patients specifically select outcomes that are relevant to them and then rate their relative importance.